NTRK1 fusion molecules and uses thereof
US11578372B2 · kind B2 · utility
4Cited by
187References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 14, 2019 |
| Grant date | Feb 14, 2023 |
| Priority date | — |
| Expiry date | May 21, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/158
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel NTRK1 fusion molecules, detection reagents, and uses and kits for evaluating, identifying, assessing and/or treating a subject having a cancer are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.